JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB199343

Anti-Glypican 1/ GPC1 antibody [EPR19285]

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal Glypican 1/ GPC1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 8 publications.

View Alternative Names

Glypican-1, GPC1

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized MDA-MB-231 (Human breast adenocarcinoma cell line) cells labeling Glypican 1/ GPC1 with ab199343 at 1/500 dilution followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing membrane associated and cytoplasmic staining on MDA-MB-231 cell line.

The nuclear counterstain is DAPI (blue).

Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is ab150077 at 1/1000 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)

Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized MCF7 (Human breast adenocarcinoma cell line) cells labeling Glypican 1/ GPC1 with ab199343 at 1/500 dilution followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).

Confocal image showing cytoplasmic staining on MCF7 cell line.

The nuclear counterstain is DAPI (blue).

Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is ab150077 at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed MDA-MB-231 (Human breast adenocarcinoma cell line) cells labeling Glypican 1/ GPC1 with ab199343 at 1/60 dilution (red) compared with a RabbitIgG,monoclonal[EPR25A]-Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.

Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)
  • WB

Supplier Data

Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)

Blocking/Dilution buffer : 5% NFDM/TBST.

The molecular weight observed is consistent with the literature (PMID : 9802880).

All lanes:

Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343) at 1/1000 dilution

Lane 1:

MDA-MB-231 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg

Lane 2:

MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate at 20 µg

Lane 3:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Lane 4:

K562 (Human chronic myelogenous leukemia cell line from bone marrow) whole cell lysate at 20 µg

Lane 5:

SH-SY5Y (Human neuroblastoma cell line from bone marrow) whole cell lysate at 20 µg

Lane 6:

MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 61 kDa

Observed band size: 55 kDa

false

Exposure time: 3s

Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)
  • WB

Supplier Data

Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (AB199343)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1 : 5 seconds; Lanes 2 and 3 : 10 seconds.

All lanes:

Western blot - Anti-Glypican 1/ GPC1 antibody [EPR19285] (ab199343) at 1/1000 dilution

Lane 1:

Human fetal kidney lysate at 10 µg

Lane 2:

Human colon lysate at 10 µg

Lane 3:

Human fetal spleen lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 61 kDa

Observed band size: 55 kDa

false

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Glypican 1/ GPC1 antibody [EPR19285]

  • Carrier free

    Anti-Glypican 1/ GPC1 antibody [EPR19285] - BSA and Azide free

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Glypican 1/ GPC1 antibody [EPR19285]

  • 660 APC

    APC Anti-Glypican 1/ GPC1 antibody [EPR19285]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Glypican 1/ GPC1 antibody [EPR19285]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Glypican 1/ GPC1 antibody [EPR19285]

  • 578 PE

    PE Anti-Glypican 1/ GPC1 antibody [EPR19285]

  • Carrier free

    Anti-Glypican 1/ GPC1 antibody [EPR19285] - Low endotoxin, Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19285

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

Flow Cyt (Intra), WB, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/60", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glypican 1 (GPC1) also known as glypican-1 is a heparan sulfate proteoglycan anchored to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor. This protein belongs to the glypican family and has an approximate mass of 60 to 70 kDa. GPC1 is found mainly on the surface of cells in the central nervous system as well as in muscle tissues and certain epithelial cells. Its structure facilitates interaction with cell surface receptors and extracellular matrix components playing an important role in cellular communication and signaling processes.
Biological function summary

GPC1 influences the regulation of growth factors and morphogens and it has a significant role in the cell division and growth processes. It is not recognized as part of any larger protein complex but interacts with diverse ligand molecules. Researchers identify GPC1 as an important facilitator of fibroblast growth factors (FGF) and sonic hedgehog (Shh) signaling. Its interaction with molecular partners helps to regulate developmental signals important for proper cellular function and organ development.

Pathways

The contributions of GPC1 are observed in the hedgehog signaling pathway and fibroblast growth factor signaling. GPC1's interaction within the hedgehog pathway is critical for organizing cellular growth and differentiation while its involvement in the FGF pathway supports angiogenesis and wound healing. GPC1 coordinates with other glypican family members and related proteins like FGFR1 to mediate these signaling processes effectively.

Researchers have linked GPC1 with cancer progression and neurodegenerative diseases. Abnormal GPC1 expression is often noted in pancreatic cancer influencing tumor growth and metastasis through its modulation of growth factor signaling. Moreover its role in neurodegenerative conditions such as Alzheimer's disease establishes connections with amyloid-beta peptides and tau proteins contributing to disease pathogenesis. These associations make GPC1 an intriguing target for therapeutic intervention and a focus for ongoing medical research.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Cell surface proteoglycan that bears heparan sulfate. Binds, via the heparan sulfate side chains, alpha-4 (V) collagen and participates in Schwann cell myelination (By similarity). May act as a catalyst in increasing the rate of conversion of prion protein PRPN(C) to PRNP(Sc) via associating (via the heparan sulfate side chains) with both forms of PRPN, targeting them to lipid rafts and facilitating their interaction. Required for proper skeletal muscle differentiation by sequestering FGF2 in lipid rafts preventing its binding to receptors (FGFRs) and inhibiting the FGF-mediated signaling.
See full target information GPC1

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Molecular & cellular oncology 10:2238873 PubMed37649964

2023

Silencing Glypican-1 enhances the antitumor effects of Pictilisib via downregulating PI3K/Akt/ERK signaling in chemo-resistant esophageal adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Akshay Pratap,Andrea Qualman,Hedlund Garrett,Lindsey Westbrook,Erlinda The,Sanchayita Mitra,Mila Cordero,Kenneth Meza Monge,Juan-Pablo Idrovo,Argudit Chauhan,Linling Cheng,Mitchell Jay Cohen,Benedetto Mungo,Sachin Wani,Robert Alexander Meguid,Martin D McCarter,Xianzhong Meng

BMC cancer 22:1023 PubMed36171564

2022

Proteomics profiling identifies extracellular vesicles' cargo associated with tumour cell induced platelet aggregation.

Applications

Unspecified application

Species

Unspecified reactive species

Niamh McNamee,Laura Rodriguez de la Fuente,Maria Jose Santos-Martinez,Lorraine O'Driscoll

Cancers 14: PubMed35884424

2022

Isolation of Circulating Tumor Cells from Seminal Fluid of Patients with Prostate Cancer Using Inertial Microfluidics.

Applications

Unspecified application

Species

Unspecified reactive species

Alexey S Rzhevskiy,Alina Y Kapitannikova,Steven A Vasilescu,Tamilla A Karashaeva,Sajad Razavi Bazaz,Mark S Taratkin,Dmitry V Enikeev,Vladimir Y Lekarev,Evgeniy V Shpot,Denis V Butnaru,Sergey M Deyev,Jean Paul Thiery,Andrei V Zvyagin,Majid Ebrahimi Warkiani

Nature cell biology 23:1240-1254 PubMed34887515

2021

Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets.

Applications

Unspecified application

Species

Unspecified reactive species

Qin Zhang,Dennis K Jeppesen,James N Higginbotham,Ramona Graves-Deal,Vincent Q Trinh,Marisol A Ramirez,Yoojin Sohn,Abigail C Neininger,Nilay Taneja,Eliot T McKinley,Hiroaki Niitsu,Zheng Cao,Rachel Evans,Sarah E Glass,Kevin C Ray,William H Fissell,Salisha Hill,Kristie Lindsey Rose,Won Jae Huh,Mary Kay Washington,Gregory Daniel Ayers,Dylan T Burnette,Shivani Sharma,Leonard H Rome,Jeffrey L Franklin,Youngmin A Lee,Qi Liu,Robert J Coffey

Oncology letters 20:197 PubMed32963603

2020

High glypican-1 expression is a prognostic factor for predicting a poor clinical prognosis in patients with hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Guoyong Chen,Hao Wu,Lei Zhang,Sidong Wei

Scientific reports 10:13572 PubMed32782317

2020

The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers.

Applications

Unspecified application

Species

Unspecified reactive species

Yousef Risha,Zoran Minic,Shahrokh M Ghobadloo,Maxim V Berezovski

International journal of nanomedicine 13:6809-6827 PubMed30425490

2018

Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wenli Qiu,Rong Chen,Xiao Chen,Huifeng Zhang,Lina Song,Wenjing Cui,Jingjing Zhang,Dandan Ye,Yifen Zhang,Zhongqiu Wang

Glycoconjugate journal 34:661-669 PubMed28822024

2017

Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Guoyun Li,Lingyun Li,Eun Ji Joo,Ji Woong Son,Young Jin Kim,Jae Ku Kang,Kyung Bok Lee,Fuming Zhang,Robert J Linhardt
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com